AZN.L |
ASTRAZENECA PLC |
|
5.73% |
|
|
|
|
|
|
|
|
|
---|
GILD |
Gilead Sciences, Inc. |
0 |
5.60% |
|
|
|
|
|
N/A |
0.00% |
45.18% |
73.01% |
---|
REGN |
Regeneron Pharmaceuticals, Inc. |
0 |
4.95% |
|
|
|
|
|
N/A |
0.00% |
40.67% |
53.12% |
---|
ARGX |
argenx SE |
0 |
4.89% |
|
|
|
|
|
N/A |
0.00% |
31.77% |
27.68% |
---|
INCY |
Incyte Corporation |
0 |
4.43% |
|
|
|
|
|
N/A |
0.00% |
42.37% |
45.07% |
---|
RVMD |
Revolution Medicines, Inc. |
0 |
4.24% |
|
|
|
|
|
N/A |
0.00% |
66.81% |
45.98% |
---|
BPMC |
Blueprint Medicines Corporation |
0 |
4.23% |
|
|
|
|
|
N/A |
0.00% |
66.68% |
-1.50% |
---|
ILMN |
Illumina, Inc. |
0 |
4.06% |
|
|
|
|
|
N/A |
0.00% |
41.31% |
22.70% |
---|
4519.T |
CHUGAI PHARMACEUTICAL CO., LTD. |
|
3.86% |
|
|
|
|
|
|
|
|
|
---|
EXEL |
Exelixis, Inc. |
0 |
3.51% |
|
|
|
|
|
N/A |
0.00% |
35.76% |
25.36% |
---|
4568.T |
DAIICHI SANKYO CO., LTD. |
|
3.10% |
|
|
|
|
|
|
|
|
|
---|
MREO |
Mereo BioPharma Group plc |
0 |
2.75% |
|
|
|
|
|
N/A |
0.00% |
268.97% |
72.63% |
---|
GMAB |
Genmab A/S |
0 |
2.61% |
|
|
|
|
|
N/A |
0.00% |
74.56% |
47.75% |
---|
BGNE |
BEIGENE LTD. |
|
2.40% |
|
|
|
|
|
|
|
|
|
---|
MRK |
Merck & Co., Inc. |
0 |
2.38% |
|
|
|
|
|
N/A |
0.00% |
36.29% |
48.54% |
---|
SWTX |
SpringWorks Therapeutics, Inc. |
0 |
2.36% |
|
|
|
|
|
N/A |
0.00% |
27.90% |
4.64% |
---|
GH |
Guardant Health, Inc. |
0 |
2.32% |
|
|
|
|
|
N/A |
0.00% |
66.47% |
22.25% |
---|
CRSP |
CRISPR Therapeutics AG |
0 |
2.18% |
|
|
|
|
|
N/A |
0.00% |
54.77% |
39.68% |
---|
NOVN.SW |
NOVARTIS AG |
|
2.13% |
|
|
|
|
|
|
|
|
|
---|
NUVL |
Nuvalent, Inc. |
0 |
1.97% |
|
|
|
|
|
N/A |
0.00% |
47.10% |
50.09% |
---|
DAWN |
Day One Biopharmaceuticals, Inc. |
0 |
1.90% |
|
|
|
|
|
N/A |
0.00% |
62.90% |
59.51% |
---|
EXAS |
Exact Sciences Corporation |
0 |
1.82% |
|
|
|
|
|
N/A |
0.00% |
46.55% |
11.01% |
---|
AGIO |
Agios Pharmaceuticals, Inc. |
0 |
1.81% |
|
|
|
|
|
N/A |
0.00% |
67.83% |
40.49% |
---|
CLDX |
Celldex Therapeutics, Inc. |
0 |
1.58% |
|
|
|
|
|
N/A |
0.00% |
48.11% |
30.11% |
---|
LNTH |
Lantheus Holdings, Inc. |
0 |
1.55% |
|
|
|
|
|
N/A |
0.00% |
51.61% |
19.41% |
---|
AMGN |
Amgen Inc. |
0 |
1.48% |
|
|
|
|
|
N/A |
0.00% |
34.50% |
47.20% |
---|
SDGR |
Schrödinger, Inc. |
0 |
1.45% |
|
|
|
|
|
N/A |
0.00% |
64.27% |
46.02% |
---|
NTLA |
Intellia Therapeutics, Inc. |
0 |
1.39% |
|
|
|
|
|
N/A |
0.00% |
84.48% |
58.18% |
---|
SHL.DE |
SIEMENS HEALTHINEERS AG |
|
1.36% |
|
|
|
|
|
|
|
|
|
---|
MRUS |
Merus N.V. |
0 |
1.29% |
|
|
|
|
|
N/A |
0.00% |
47.93% |
31.19% |
---|
ACLX |
Arcellx, Inc. |
0 |
1.25% |
|
|
|
|
|
N/A |
0.00% |
46.12% |
38.93% |
---|
BNTX |
BioNTech SE |
0 |
1.08% |
|
|
|
|
|
N/A |
0.00% |
45.15% |
32.29% |
---|
SMMT |
Summit Therapeutics Inc. |
0 |
1.02% |
|
|
|
|
|
N/A |
0.00% |
47.40% |
15.30% |
---|
NRIX |
Nurix Therapeutics, Inc. |
0 |
0.91% |
|
|
|
|
|
N/A |
0.00% |
80.19% |
27.11% |
---|
IDYA |
IDEAYA Biosciences, Inc. |
0 |
0.85% |
|
|
|
|
|
N/A |
0.00% |
142.62% |
25.74% |
---|
COGT |
Cogent Biosciences, Inc. |
0 |
0.85% |
|
|
|
|
|
N/A |
0.00% |
389.75% |
60.67% |
---|
MRNA |
Moderna, Inc. |
0 |
0.80% |
|
|
|
|
|
N/A |
0.00% |
67.24% |
33.78% |
---|
ORIC |
ORIC Pharmaceuticals, Inc. |
0 |
0.79% |
|
|
|
|
|
N/A |
0.00% |
178.18% |
11.05% |
---|
LEGN |
Legend Biotech Corporation |
0 |
0.78% |
|
|
|
|
|
N/A |
0.00% |
65.05% |
22.13% |
---|
CGEM |
Cullinan Oncology, Inc. |
0 |
0.72% |
|
|
|
|
|
N/A |
0.00% |
173.08% |
44.21% |
---|
RCUS |
Arcus Biosciences, Inc. |
0 |
0.72% |
|
|
|
|
|
N/A |
0.00% |
286.49% |
76.20% |
---|
IMCR |
Immunocore Holdings plc |
0 |
0.69% |
|
|
|
|
|
N/A |
0.00% |
80.23% |
12.31% |
---|
BCYC |
Bicycle Therapeutics plc |
0 |
0.60% |
|
|
|
|
|
N/A |
0.00% |
250.22% |
75.08% |
---|
JANX |
Janux Therapeutics, Inc. |
0 |
0.60% |
|
|
|
|
|
N/A |
0.00% |
81.13% |
18.74% |
---|
RLAY |
Relay Therapeutics, Inc. |
0 |
0.59% |
|
|
|
|
|
N/A |
0.00% |
137.21% |
50.43% |
---|
TERN |
Terns Pharmaceuticals, Inc. |
0 |
0.59% |
|
|
|
|
|
N/A |
0.00% |
732.53% |
37.07% |
---|
JSPR |
Jasper Therapeutics, Inc. |
0 |
0.58% |
|
|
|
|
|
N/A |
0.00% |
140.84% |
37.33% |
---|
CGON |
CG Oncology, Inc. Common stock |
0 |
0.53% |
|
|
|
|
|
N/A |
0.00% |
102.73% |
12.07% |
---|
ARVN |
Arvinas, Inc. |
0 |
0.39% |
|
|
|
|
|
N/A |
0.00% |
150.95% |
32.38% |
---|
CRBP |
Corbus Pharmaceuticals Holdings, Inc. |
0 |
N/A |
|
|
|
|
|
N/A |
0.00% |
174.75% |
46.22% |
---|